SCHEMBL5128658

SCHEMBL5128658

O=C(COCC1CCCN1S(=O)(=O)c1c(Cl)cc(C(F)(F)F)cc1Cl)N1CCC(O)(c2ccc(Cl)c(C(F)(F)F)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 16/20 0.45
OPRL1 P41146 9/20 0.45
OPRD1 P41143 9/20 0.45
OPRK1 P41145 8/20 0.45
SCN1A P35498 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN3A Q9NY46 1/20 0.39
HTR1A P08908 7/20 0.37
DRD2 P14416 7/20 0.37
DRD4 P21917 7/20 0.37
HTR1D P28221 7/20 0.37
HTR2A P28223 7/20 0.37
HTR2C P28335 7/20 0.37
HTR7 P34969 7/20 0.37
DRD1 P21728 6/20 0.37
DRD5 P21918 6/20 0.37
SLC6A2 P23975 6/20 0.37
SLC6A4 P31645 6/20 0.37
DRD3 P35462 6/20 0.37
HTR2B P41595 6/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131363 0.98 OPRM1 (0.47) OPRM1OPRL1OPRD1OPRK1SCN1A
SCHEMBL5127145 0.93 OPRM1 (0.46) OPRM1OPRL1OPRD1OPRK1SCN1A
SCHEMBL3821931 0.92 S1PR2 (0.43) OPRL1DRD2DRD4DRD3CASP1
SCHEMBL5126207 0.91 OPRM1 (0.47) OPRM1OPRL1OPRD1OPRK1SCN1A
SCHEMBL5123720 0.90 S1PR2 (0.42) OPRM1OPRL1OPRD1OPRK1DRD2
SCHEMBL5128309 0.90 CHRM4 (0.45) OPRM1OPRL1OPRD1OPRK1SIGMAR1
SCHEMBL5127990 0.90 CHRM4 (0.41) CASP1CASP3CASP7
SCHEMBL5128532 0.88 SIGMAR1 (0.44) OPRM1OPRL1OPRD1OPRK1SCN1A
SCHEMBL5128613 0.88 OPRL1 (0.44) OPRM1OPRL1OPRD1OPRK1SIGMAR1
SCHEMBL3827383 0.88 CHRM4 (0.40) OPRM1OPRL1OPRK1CASP1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249128-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-10-09 US claimed
US-8580965-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-11-12 US disclosed
US-20080249128-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249128-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, NPSR1 OPRM1 232/4885OPRL1 10/4885OPRD1 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.